Skip to main content

Table 5 Cut-off score of Hsp90-beta level for differentiating lung cancer patients from control individuals

From: Elevated Hsp90-beta contributes to differential diagnosis of pleural effusion caused by lung cancer and correlates with malignant biological behavior of lung cancer

Criterion

Sensitivity

95% CI

Specificity

95% CI

Cut-off score for serum Hsp90-beta for differentiating lung cancer patient from control individuals

  > =0.608

100.00

96.6–100.0

0.00

0.0–7.1

  > 0.888

92.52

85.8–96.7

60.00

45.2–73.6

  > 0.978

92.52

85.8–96.7

74.00

59.7–85.4

  > 1.228 *

84.11

75.8–90.5

86.00

73.3–94.2

  > 1.468

8.41

3.9–15.4

86.00

73.3–94.2

  > 1.689

0.00

0.0–3.4

96.00

86.3–99.5

  > 1.752

0.00

0.0–3.4

100.00

92.9–100.0

Cut-off score for MPE Hsp90-beta for differentiating lung cancer patient from control individuals

  > =1.048

100.00

96.6–100.0

0.00

0.0–7.1

  > 1.188

97.20

92.0–99.4

38.00

24.7–52.8

  > 1.286

93.46

87.0–97.3

71.00

57.5–83.8

  > 1.659 *

93.46

87.0–97.3

79.00

71.3–90.2

  > 1.786

50.47

40.6–60.3

86.00

73.3–94.2

  > 1.988

5.61

2.1–11.8

90.00

78.2–96.7

  > 2.058

0.93

0.02–5.1

94.00

83.5–98.7

  1. 95% CI 95% confidence; *cut-off value